Filing Flows › Opko Health (OPK) › Q2 2026
Opko Health (OPK) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 27, 2026
Opko Health (OPK) reported revenue of $164M for the second quarter 2026 (Q2 2026), +4% from a year earlier and +32% from the quarter before. Operating margin was -4.3%, net loss $8.4M (5.1% of revenue).
Opko Health, Q2 2026: revenue $164M (+4% year over year), operating margin -4.3%, net loss $8.4M, operating cash flow −$43.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $164M | +32% | +4% |
| Operating profit | −$7.0M | — | — |
| Net earnings | −$8.4M | — | — |
| Operating cash flow | −$43.5M | — | — |
What changed
Revenue was $163.6M in Q2 2026, up 4% year over year and up 32% from the previous quarter. Service was the largest line at 46% of revenue. Intellectual Property and Other added $31.1M year over year (up 207%), 459% of the total change. Service declined 26%.
Gross margin was 48.9%, up 17.4 points from Q2 2025. Operating costs exceeded revenue by $7.0M, an operating margin of -4.3%. Operating expenses fell 20% while revenue rose 4%. The quarter ended with a net loss of $8.4M, narrower than the previous quarter's $54.8M loss. Net interest and other expense of $6.4M was the main reason.
Operating cash flow was −$43.5M. Non-cash charges added back $22.4M of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items used $59.7M. Capital expenditures of $3.0M exceeded it, leaving free cash flow of −$46.5M.
Questions
What was Opko Health's revenue in the second quarter 2026?
Opko Health (OPK) reported revenue of $164M for the second quarter 2026 (Q2 2026), +4% from a year earlier and +32% from the quarter before.
Was Opko Health profitable in the second quarter 2026?
Operating loss was $7.0M (-4.3% of revenue) and net loss $8.4M.
Source: Opko Health 10-Q on SEC EDGAR.